Key facts
- This page summarizes Patrick A. Barry's Form 4 filing for Indivior Pharmaceuticals, Inc. (INDV).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Feb 2026, 16:03.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer.
SEC remarks
Exhibit 24 Power of Attorney